TTJ-17993-95013
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 711 / LA
- Registered
- 2021-08-14
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-14
Registered in v-safe
-
2021-08-14
Dose 1 — Pfizer-BioNTech
- 2021-08-14
- 2021-08-15
-
2021-08-16
Survey response — days 1–6 daily, dose 1MedDRA: Chest discomfort — Feeling: FairFree text: Discomfort in chestMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-17
- 2021-08-18
- 2021-08-19
-
2021-08-20
Survey response — days 1–6 daily, dose 1MedDRA: Chest discomfort — Feeling: FairFree text: Chest discomfortMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-21
- 2021-08-28
-
2021-09-04
Dose 2 — Pfizer-BioNTech
- 2021-09-04
- 2021-09-05
- 2021-09-06
- 2021-09-07
- 2021-09-08
- 2021-09-09
- 2021-09-10
- 2021-09-11
- 2021-09-18
- 2021-09-25
- 2021-10-02
-
2021-10-09
Survey response — day 35, dose 2MedDRA: Hypertension — Feeling: Fair · Get care from a doctor or other healthcare professional · HospitalizationFree text: High blood pressureMedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2021-10-12
- 2021-10-16
-
2021-12-06
Survey response — 3 months, dose 2MedDRA: Chest pain, Dizziness, Dyspnoea, Fatigue, Heart rate increased, Hypertension, Visual impairment — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Fast heart rate, dizziness, fatigue, chest pains, shortness of breath, vision changes, high blood pressureMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2021-12-07
Call successfulParticipant prefers to complete VAERS report online
- 2022-03-05
- 2022-09-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-14 | Pfizer-BioNTech | No |
| 2 | 2021-09-04 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Discomfort in chest
Systemic reaction (other): Chest discomfort
Release 10 — day 35, dose 2
Symptoms: High blood pressure
Release 10 — 3 months, dose 2
Symptoms: Fast heart rate, dizziness, fatigue, chest pains, shortness of breath, vision changes, high blood pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Chest discomfort | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release